Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma
Ganna Oliynyk, María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, et al.
iScience (2019) Vol. 21, pp. 188-204
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Targeting mitochondrial metabolism for precision medicine in cancer
Lourdes Sainero‐Alcolado, Judit Liaño-Pons, María Victoria Ruiz-Pérez, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 7, pp. 1304-1317
Open Access | Times Cited: 183
MYCN Function in Neuroblastoma Development
Jörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 127
Retinoblastoma Origins and Destinations
David Cobrinik
New England Journal of Medicine (2024) Vol. 390, Iss. 15, pp. 1408-1419
Closed Access | Times Cited: 18
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
Huajie Song, Dan Li, Xiaojing Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
Nicole Anderson, Xiaodan Qin, Jennifer M. Finan, et al.
Cancer Research (2021) Vol. 81, Iss. 17, pp. 4417-4430
Open Access | Times Cited: 47
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumors
Panayotis Pachnis, Zheng Wu, Brandon Faubert, et al.
Science Advances (2022) Vol. 8, Iss. 35
Open Access | Times Cited: 34
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
Fabrizio Fontana, Patrízia Limonta
Free Radical Biology and Medicine (2021) Vol. 176, pp. 203-221
Closed Access | Times Cited: 33
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
Thale Kristin Olsen, Cecilia Dyberg, Bethel Tesfai Embaie, et al.
JCI Insight (2022) Vol. 7, Iss. 17
Open Access | Times Cited: 23
MYCN and Metabolic Reprogramming in Neuroblastoma
Mohit Bansal, Anamika Gupta, Han‐Fei Ding
Cancers (2022) Vol. 14, Iss. 17, pp. 4113-4113
Open Access | Times Cited: 23
A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastoma
Xin Yu
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 253-273
Open Access | Times Cited: 4
Dietary Modulation of Fatty Acid Oxidation Imparts Stem Cell Protection in Bone Marrow
Nawaz Ahmed, Sarah Walker, Alessia Roma, et al.
Nutrition and Cancer (2025), pp. 1-7
Closed Access
Targeting tumor angiogenesis and metabolism: a new perspective in pediatric thoracic tumor therapy
Yong Lv, F. Shu, Dan Luo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells
Go J. Yoshida
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 30
Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma
María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, Ganna Oliynyk, et al.
iScience (2021) Vol. 24, Iss. 2, pp. 102128-102128
Open Access | Times Cited: 24
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Britta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma
Kausik Bishayee, Uddin Md. Nazim, Vijay Kumar, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113032-113032
Open Access | Times Cited: 14
FAM201A encodes small protein NBASP to inhibit neuroblastoma progression via inactivating MAPK pathway mediated by FABP5
Mujie Ye, Runnan Gao, Shiyu Chen, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
Karolina Borankova, Mária Krchniaková, Lionel Yi Wen Leck, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 7
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
GAPDH in neuroblastoma: Functions in metabolism and survival
Kevin Cornett, Anna Puderbaugh, Olivia Back, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition
Vittoria Graziani, Aida Rodriguez‐Garcia, Lourdes Sainero Alcolado, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Metabolic protein kinase signalling in neuroblastoma
William J. Smiles, Luca Catalano, Victoria E. Stefan, et al.
Molecular Metabolism (2023) Vol. 75, pp. 101771-101771
Open Access | Times Cited: 6
Defining neuroblastoma: from origin to precision medicine
Lourdes Sainero‐Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2174-2192
Open Access | Times Cited: 2
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
Venugopal Gunda, Anup Singh Pathania, Srinivas Chava, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2576-2576
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top